Bioavailability and pharmacokinetics of methotrexate and its metabolite 7-hydroxy-MTX after low-dose MTX (25 mg) in patients with chronic rheumatoid diseases. - Körber,H.; Iven,H.; Gross,W.L. (Arthritis Rheum, 1992)